As such, FGF23 was reported to exert Klotho-independent effects in the myocardium and directly contribute to left ventricular hypertrophy, a prevalent manifestation and well-established cardiovascular risk factor in CKD [10]. Here, FGF23 is linked to chronic kidney disease.